According to the Japanese gastric cancer treatment guidelines [1], oral fluoropyrimidine plus platinum is the standard first-line chemotherapy for human epidermal growth factor receptor 2 (HER2)-negative unresectable AGC [2–6]. This evidence concerns the gene ERBB2 and gastric cancer.